Market Overview

Amgen To Acquire KAI Pharmaceuticals For $315M

Amgen Inc (NASDAQ: AMGN) announced its plans to buy privately-held KAI Pharmaceuticals for $315 million in cash.

AMGN shares closed at $67.02 yesterday.

Posted-In: merger and acquisitionNews M&A

 

Related Articles (AMGN)

Around the Web, We're Loving...

Get Benzinga's Newsletters